Mexican Diabetes Therapy Market


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and products have been introduced into this market, splitting the diabetes therapy business in three segments: insulin, anti diabetes drugs and self monitoring accessories. Therefore, pharmaceutical companies face a tough competitive environment, in order to gain public and private healthcare sectors’ share.

Table of Contents

Mexican Diabetes Therapy Market, Mexican Market Introduction and Executive SummaryMarket Introduction and Executive SummaryExecutive SummaryOverview of the Mexican Healthcare SystemThe Diabetes Business within the Mexican Pharmaceutical MarketMexico – Diabetes Therapy MarketMarket MeasurementsIndustry ChallengesMarket DriversMarket RestraintsMarket Forecast by SegmentInsulinAntidiabetes DrugsSelf-monitoring AccessoriesCompetitive Analysis and Market ShareInsulinAntidiabetes DrugsSelf-monitoring Accessories

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.